GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

Other languages Genomma Lab Internacional, S.A.B. de C.V.

Equities

LAB B

MX01LA010006

End-of-day quote Mexican S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
17.77 ^MXN	-4.51%		+6.53%	+25.49%

Apr. 25	Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q1 2024 Earnings Call, Apr 25, 2024
Apr. 24	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24
Genomma Lab Internacional B de C : 1Q-2024 Earnings Call Advisory	Apr. 10
Ex-dividend day for interim dividend	Mar. 20	FA
Genomma Lab Internacional, S.A.B. De C.V. Declares Cash Dividend	Mar. 13
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21
Ex-dividend day for interim dividend	Dec. 21	FA
Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend Payment	Dec. 13
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America	Nov. 29
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24
Genomma Lab Internacional B de C : 3Q-2023 Earnings Call Advisory	23-10-04
Ex-dividend day for interim dividend	23-09-26	FA
Genomma Lab Internacional B de C : MANUFACTURING FACILITY GRANTED COFEPRIS OPERATING LICENSE FOR ALL ITS PHARMA / OTC MANUFACTURING LINES	23-08-06
Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q2 2023 Earnings Call, Jul 27, 2023	23-07-27
Genomma Lab Internacional B de C : Q2 2023 Earnings Release	23-07-26
Genomma Lab Internacional B de C : Our Progress Sustainability 2022	23-07-26
Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Genomma Lab Internacional, S.A.B. de C.V.

Equities

LAB B

MX01LA010006

Other languages

Filters